Furthermore, we found that our nanochaperone prominently reduced Aβ burden, attenuated Aβ‐induced inflammation, and rescued the cognitive deficits of APP/PS1 transgenic AD model mice at the early stage of disease. Here, APP is linked to Alzheimer disease.